Trending Stocks Alert: My Size, Inc. (NASDAQ:MYSZ), Kadmon Holdings, Inc. (NYSE:KDMN)

10

My Size, Inc. (NASDAQ:MYSZ)

My Size, Inc. is involved in the development of applications for apparel businesses. It offers MySize ID, an application which enables consumers to create a secure, online profile of their personal measurements to get the right fit. My Size, Inc. is based in Airport City, Israel.

My Size, Inc. (NASDAQ:MYSZ)’s Financial Overview

My Size, Inc. (NASDAQ) surged 0% yesterday to close its trading session at $1.02. The company has 1 year Price Target of $0.15. My Size, Inc. has 52-Week high of $3.58 and 52-Week Low of $0.57. The stock touched its 52-Week High on 3.58 and 52-Week Low on 0.57. The stock traded with the volume of 0 shares yesterday. The firm shows the market capitalization of $30.3 Million.

My Size, Inc. (NASDAQ) reported its last quarterly earnings on 12/30/2007 where the firm reported its Actual EPS of $0.13/share against the analyst consensus estimate of $0.18/share. The difference between the actual and expected EPS is $-0.05 a share with a surprise factor of -27.8%.

The firm is trading with SMA20 of -5.76 Percent, SMA50 of -4.71 Percent and SMA200 of -8.6 percent. My Size, Inc. has P/S value of 0 while its P/B value stands at 4.36. Similarly, the company has Return on Assets of 0 percent, Return on Equity of 0 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 3 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

There is no forecast data available.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Kadmon Holdings, Inc. (NYSE:KDMN)

Kadmon Holdings, Inc. is a biopharmaceutical company. It engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. The company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases. Kadmon Holdings, Inc. is headquartered in New York.

Kadmon Holdings, Inc. (NYSE:KDMN)’s Financial Outlook

The 5 analysts offering 12-month price forecasts for Kadmon Holdings Inc have a median target of 6.50, with a high estimate of 25.00 and a low estimate of 2.90. The median estimate represents a +160.00% increase from the last price of 2.50.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Kadmon Holdings, Inc. has a Consensus Recommendation of 1.5. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock surged 0% and closed its last trading session at $2.5. The company has the market capitalization of $287.5 Million. The stock has 52-week high of $5.86 and 52-Week low of $1.88. The firm touched its 52-Week high on 5.86 and 52-Week low on 1.88. The company has volume of 0 shares. The company has a total of 115 Million shares outstanding.

Kadmon Holdings, Inc. (NYSE) in the last quarter reported its actual EPS of $-0.13/share where the analyst estimated EPS was $-0.23/share. The difference between the actual and Estimated EPS is $0.1. This shows a surprise factor of 43.5 percent.

The company has YTD performance of -30.94 percent. Beta for Kadmon Holdings, Inc. stands at 0 while its ATR (average true range) is 0.22. The company has Weekly Volatility of 9.14%% and Monthly Volatility of 8.28%%.

Kadmon Holdings, Inc. has distance from 20-day Simple Moving Average (SMA20) of -3.04%, Distance from 50-Day Simple Moving Average of -7.53 percent and Distance from 200-Day Simple Moving Average of -28.85%.

The Company currently has ROA (Return on Assets) of -25.7 percent, Return on Equity (ROE) of -116.9 Percent and Return on Investment (ROI) of 1464.6% with Gross margin of 68.6 percent and Operating & Profit margin of 0% and 0% respectively.

SHARE